162 related articles for article (PubMed ID: 25792834)
1. New findings about iron oxide nanoparticles and their different effects on murine primary brain cells.
Neubert J; Wagner S; Kiwit J; Bräuer AU; Glumm J
Int J Nanomedicine; 2015; 10():2033-49. PubMed ID: 25792834
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility of very small superparamagnetic iron oxide nanoparticles in murine organotypic hippocampal slice cultures and the role of microglia.
Pohland M; Glumm R; Wiekhorst F; Kiwit J; Glumm J
Int J Nanomedicine; 2017; 12():1577-1591. PubMed ID: 28280327
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal iron liberation is responsible for the vulnerability of brain microglial cells to iron oxide nanoparticles: comparison with neurons and astrocytes.
Petters C; Thiel K; Dringen R
Nanotoxicology; 2016; 10(3):332-42. PubMed ID: 26287375
[TBL] [Abstract][Full Text] [Related]
4. Cellular magnetic resonance with iron oxide nanoparticles: long-term persistence of SPIO signal in the CNS after transplanted cell death.
Cianciaruso C; Pagani A; Martelli C; Bacigaluppi M; Squadrito ML; Lo Dico A; De Palma M; Furlan R; Lucignani G; Falini A; Biffi A; Ottobrini L; Politi LS
Nanomedicine (Lond); 2014 Jul; 9(10):1457-74. PubMed ID: 24823433
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and proliferative capacity impairment induced on human brain cell cultures after short- and long-term exposure to magnetite nanoparticles.
Coccini T; Caloni F; Ramírez Cando LJ; De Simone U
J Appl Toxicol; 2017 Mar; 37(3):361-373. PubMed ID: 27480414
[TBL] [Abstract][Full Text] [Related]
6. Endocytotic uptake of iron oxide nanoparticles by cultured brain microglial cells.
Luther EM; Petters C; Bulcke F; Kaltz A; Thiel K; Bickmeyer U; Dringen R
Acta Biomater; 2013 Sep; 9(9):8454-65. PubMed ID: 23727247
[TBL] [Abstract][Full Text] [Related]
7. Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function.
Oude Engberink RD; van der Pol SM; Döpp EA; de Vries HE; Blezer EL
Radiology; 2007 May; 243(2):467-74. PubMed ID: 17456871
[TBL] [Abstract][Full Text] [Related]
8. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency.
Matuszewski L; Persigehl T; Wall A; Schwindt W; Tombach B; Fobker M; Poremba C; Ebert W; Heindel W; Bremer C
Radiology; 2005 Apr; 235(1):155-61. PubMed ID: 15749976
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests.
Costa C; Brandão F; Bessa MJ; Costa S; Valdiglesias V; Kiliç G; Fernández-Bertólez N; Quaresma P; Pereira E; Pásaro E; Laffon B; Teixeira JP
J Appl Toxicol; 2016 Mar; 36(3):361-72. PubMed ID: 26212026
[TBL] [Abstract][Full Text] [Related]
10. Intracellular SPIO labeling of microglia: high field considerations and limitations for MR microscopy.
Rosenberg JT; Sachi-Kocher A; Davidson MW; Grant SC
Contrast Media Mol Imaging; 2012; 7(2):121-9. PubMed ID: 22434624
[TBL] [Abstract][Full Text] [Related]
11. Toxicity Evaluation of Iron Oxide (Fe₃O₄) Nanoparticles on Human Neuroblastoma-Derived SH-SY5Y Cell Line.
Ramírez-Cando LJ; De Simone U; Coccini T
J Nanosci Nanotechnol; 2017 Jan; 17(1):203-11. PubMed ID: 29617102
[TBL] [Abstract][Full Text] [Related]
12. Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes.
Puppi J; Mitry RR; Modo M; Dhawan A; Raja K; Hughes RD
Cell Transplant; 2011; 20(6):963-75. PubMed ID: 21092412
[TBL] [Abstract][Full Text] [Related]
13. Cellular interactions of functionalized superparamagnetic iron oxide nanoparticles on oligodendrocytes without detrimental side effects: Cell death induction, oxidative stress and inflammation.
Sruthi S; Maurizi L; Nury T; Sallem F; Boudon J; Riedinger JM; Millot N; Bouyer F; Lizard G
Colloids Surf B Biointerfaces; 2018 Oct; 170():454-462. PubMed ID: 29958160
[TBL] [Abstract][Full Text] [Related]
14. Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study.
Boutry S; Brunin S; Mahieu I; Laurent S; Vander Elst L; Muller RN
Contrast Media Mol Imaging; 2008; 3(6):223-32. PubMed ID: 19072771
[TBL] [Abstract][Full Text] [Related]
15. Uptake of silica nanoparticles in the brain and effects on neuronal differentiation using different in vitro models.
Ducray AD; Stojiljkovic A; Möller A; Stoffel MH; Widmer HR; Frenz M; Mevissen M
Nanomedicine; 2017 Apr; 13(3):1195-1204. PubMed ID: 27871963
[TBL] [Abstract][Full Text] [Related]
16. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
17. Effects of the iron oxide nanoparticle Molday ION Rhodamine B on the viability and regenerative function of neural stem cells: relevance to clinical translation.
Umashankar A; Corenblum MJ; Ray S; Valdez M; Yoshimaru ES; Trouard TP; Madhavan L
Int J Nanomedicine; 2016; 11():1731-48. PubMed ID: 27175074
[TBL] [Abstract][Full Text] [Related]
18. Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes.
Lunov O; Syrovets T; Röcker C; Tron K; Nienhaus GU; Rasche V; Mailänder V; Landfester K; Simmet T
Biomaterials; 2010 Dec; 31(34):9015-22. PubMed ID: 20739059
[TBL] [Abstract][Full Text] [Related]
19. Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells.
Lindemann A; Lüdtke-Buzug K; Fräderich BM; Gräfe K; Pries R; Wollenberg B
Int J Nanomedicine; 2014; 9():5025-40. PubMed ID: 25378928
[TBL] [Abstract][Full Text] [Related]
20. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells.
Kunzmann A; Andersson B; Vogt C; Feliu N; Ye F; Gabrielsson S; Toprak MS; Buerki-Thurnherr T; Laurent S; Vahter M; Krug H; Muhammed M; Scheynius A; Fadeel B
Toxicol Appl Pharmacol; 2011 Jun; 253(2):81-93. PubMed ID: 21435349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
